» Articles » PMID: 14684402

Vitamin E Bioavailability from Fortified Breakfast Cereal is Greater Than That from Encapsulated Supplements

Overview
Journal Am J Clin Nutr
Publisher Elsevier
Date 2003 Dec 20
PMID 14684402
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Conflicting results from vitamin E intervention studies suggest supplemental vitamin E malabsorption.

Objective: We compared vitamin E bioavailability from a supplement with that from a fortified breakfast cereal.

Design: Vitamin E bioavailability was evaluated by using deuterium-labeled all-rac-alpha-tocopherol in three 4-d trials (2 wk apart). Five fasting subjects sequentially consumed the following (with 236 mL fat-free milk): 400 IU d(9)-alpha-tocopheryl acetate (400-IU capsule), 41 g ready-to-eat wheat cereal containing 30 IU d(9)-alpha-tocopheryl acetate (30-IU cereal), and 45 g cereal containing 400 IU d(9)-alpha-tocopheryl acetate (400-IU cereal). Five months later (trial 4), they consumed a 400-IU capsule with 41 g vitamin E-free cereal. Blood was obtained up to 72 h after the start of each trial.

Results: The mean (+/-SD) vitamin E bioavailabilities of the 30-IU cereal and the 400-IU cereal were 6 +/- 2 and 26 +/- 8 times, respectively, the vitamin E bioavailability of the 400-IU capsule. The areas under the 0-72-h d(9)-alpha-tocopherol curves for the 400-IU capsule, the 30-IU cereal, and the 400-IU cereal were 30 +/- 7, 153 +/- 43, and 765 +/- 164 micro mol. h/L (all trial comparisons, P < 0.0001). In trial 4, 3 subjects barely responded and 2 subjects had areas under the curve that were similar to their 400-IU cereal responses.

Conclusion: The low bioavailability of vitamin E from the 400-IU capsule and the variability observed when the capsule was consumed with cereal suggest that encapsulated vitamin E is poorly absorbed when consumed with a low-fat meal and that bioavailability can be enhanced by food fortification with vitamin E.

Citing Articles

CFTR Modulator Therapy with Lumacaftor/Ivacaftor Alters Plasma Concentrations of Lipid-Soluble Vitamins A and E in Patients with Cystic Fibrosis.

Sommerburg O, Hammerling S, Schneider S, Okun J, Langhans C, Leutz-Schmidt P Antioxidants (Basel). 2021; 10(3).

PMID: 33808590 PMC: 8003491. DOI: 10.3390/antiox10030483.


Vitamin E absorption and kinetics in healthy women, as modulated by food and by fat, studied using 2 deuterium-labeled α-tocopherols in a 3-phase crossover design.

Traber M, Leonard S, Ebenuwa I, Violet P, Wang Y, Niyyati M Am J Clin Nutr. 2019; 110(5):1148-1167.

PMID: 31495886 PMC: 6821549. DOI: 10.1093/ajcn/nqz172.


Factors Associated with Increased Alpha-Tocopherol Content in Milk in Response to Maternal Supplementation with 800 IU of Vitamin E.

Reboucas A, da Silva A, Oliveira A, Silva L, de Freitas Felgueiras V, Cruz M Nutrients. 2019; 11(4).

PMID: 31013594 PMC: 6520676. DOI: 10.3390/nu11040900.


Plasma Response to Deuterium-Labeled Vitamin K Intake Varies by TG Response, but Not Age or Vitamin K Status, in Older and Younger Adults.

Ellis J, Fu X, Al Rajabi A, Grusak M, Shearer M, Naumova E J Nutr. 2018; 149(1):18-25.

PMID: 30590596 PMC: 6351140. DOI: 10.1093/jn/nxy216.


Pharmacokinetics of vitamin E, γ-oryzanol, and ferulic acid in healthy humans after the ingestion of a rice bran-enriched porridge prepared with water or with milk.

Calvo-Castro L, Sus N, Schiborr C, Bosy-Westphal A, Duran M, Fesenmeyer D Eur J Nutr. 2018; 58(5):2099-2110.

PMID: 29978378 DOI: 10.1007/s00394-018-1770-6.